A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population

A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population

ABSTRACT: Background: Concomitant therapy and bismuth quadruple therapy are both recommended as first-line treatment regimens for the empiric treatment of Helicobacter pylori infection, especially after the increased resistance to clarithromycin. Objective: Our goal was to compare both treatment re...

Full description

Saved in:
Bibliographic Details
Main Authors: Jad Chidiac, MD, Reine-Marie Kahwaji, MD, Souheil Hallit, PharmD, MSc, MPH, PhD, Yara Yazbeck, MD, Bassem Akiki, MD, Charbel Yazbeck, MD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Current Therapeutic Research
Subjects:
Bismuth quadruple therapy
Concomitant therapy
Eradication
Helicobacter pylori
First-line therapy regimen
Second-line therapy regimen
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X25000165
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items